Psych MEQs / SAQs · Specialty psychiatry — sleep medicine interface
Chronic insomnia with depression and hypnotic dependence (MEQ)
FRANZCP-style MEQ on chronic insomnia: CBT-I first-line, hypnotic dependence, OSA screen, occupational sleepiness, depression bidirectional risk. FRANZCP-primary, globally tagged.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Formulation. Chronic insomnia disorder (sleep onset and maintenance, frequency and multi-year course, daytime impairment) comorbid with residual MDD. Contributing/maintaining factors: alcohol (shortens latency but fragments architecture), long-term zopiclone with likely tolerance/dependence pattern, possible OSA (BMI, snoring). Differentials: primary vs comorbid insomnia (both treated), circadian delay less likely given description, RLS not described, medical pain/thyroid not yet excluded, substance-induced sleep disorder component from alcohol/hypnotic.[1][4][7]
(ii) Assessment/investigations. Structured sleep history and 1–2 week diary; substances; suicide risk; driving/occupational sleepiness (near-miss is a red flag). Partner history for apnoeas. ISI/ESS as clinical tools. Screen OSA (STOP-BANG-type factors). Review medications. Consider sleep study given high OSA probability; not required to start CBT-I for typical insomnia features but should not delay OSA pathway. Baseline mood scales; medical labs as indicated (TFT, FBC, glucose, etc.).[4][1]
(iii) Stepped plan. Psychoeducation; stop using alcohol as hypnotic. CBT-I first-line (stimulus control, sleep restriction with occupational safety planning, cognitive therapy, relaxation, education) — face-to-face or digital depending on access; evidence for clinically meaningful benefit.[1][2][3][7] Optimise depression treatment in parallel (not instead of CBT-I). Hypnotic deprescribing: shared plan to taper zopiclone (slow taper if dependence features), avoid dose escalation, do not replace with open-ended quetiapine for primary insomnia. Short-term bridge only if needed during CBT-I initiation with exit criteria. Sedating antidepressant choices only if depression warrants, knowing hangover/OSA weight risks.[1][7]
(iv) OSA and work. Refer sleep medicine; weight management; alcohol reduction. Pending assessment, discuss temporary work safety (no forklift if sleepy), employer/OHS liaison as appropriate, legal fitness-to-drive/operate machinery principles by jurisdiction. CPAP if moderate–severe OSA confirmed — support adherence.[4]
(v) Depression/suicide evidence. Longitudinal meta-analysis shows insomnia predicts incident depression; sleep disturbance associates with suicidal ideation/attempt/death — document SI carefully and treat sleep as part of risk reduction, not optional comfort care.[5][6]
Common errors
- Only increasing zopiclone dose.
- Ignoring OSA and alcohol.
- Claiming CBT-I is “optional lifestyle advice.”
- Discharging without occupational near-miss plan.
- Treating insomnia as purely secondary and waiting for mood to remiss fully before any sleep treatment. [1][2][6]
Examiner notes
Award marks for simultaneous CBT-I + depression optimisation + OSA pathway + deprescribing + risk. Full marks require evidence-linked first-line CBT-I (ACP/AASM/Europe) and suicide/depression bidirectionality. [1][2][5]
References
- [1]Qaseem A, Kansagara D, Forciea MA, et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians Ann Intern Med, 2016.PMID 27136449
- [2]Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline J Clin Sleep Med, 2021.PMID 33164742
- [3]Trauer JM, Qian MY, Doyle JS, et al. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis Ann Intern Med, 2015.PMID 26054060
- [4]Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults Am J Epidemiol, 2013.PMID 23589584
- [5]Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies J Affect Disord, 2011.PMID 21300408
- [6]Pigeon WR, Pinquart M, Conner K Meta-analysis of sleep disturbance and suicidal thoughts and behaviors J Clin Psychiatry, 2012.PMID 23059158
- [7]Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia J Sleep Res, 2017.PMID 28875581
- [8]Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits BMJ, 2005.PMID 16284208